Unknown

Dataset Information

0

Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.


ABSTRACT:

Background and purpose

Neutrophil overstimulation plays a crucial role in tissue damage during severe infections. Because pathogen-derived neuraminidase (NEU) stimulates neutrophils, we investigated whether host NEU can be targeted to regulate the neutrophil dysregulation observed in severe infections.

Experimental approach

The effects of NEU inhibitors on lipopolysaccharide (LPS)-stimulated neutrophils from healthy donors or COVID-19 patients were determined by evaluating the shedding of surface sialic acids, cell activation, and reactive oxygen species (ROS) production. Re-analysis of single-cell RNA sequencing of respiratory tract samples from COVID-19 patients also was carried out. The effects of oseltamivir on sepsis and betacoronavirus-induced acute lung injury were evaluated in murine models.

Key results

Oseltamivir and zanamivir constrained host NEU activity, surface sialic acid release, cell activation, and ROS production by LPS-activated human neutrophils. Mechanistically, LPS increased the interaction of NEU1 with matrix metalloproteinase 9 (MMP-9). Inhibition of MMP-9 prevented LPS-induced NEU activity and neutrophil response. In vivo, treatment with oseltamivir fine-tuned neutrophil migration and improved infection control as well as host survival in peritonitis and pneumonia sepsis. NEU1 also is highly expressed in neutrophils from COVID-19 patients, and treatment of whole-blood samples from these patients with either oseltamivir or zanamivir reduced neutrophil overactivation. Oseltamivir treatment of intranasally infected mice with the mouse hepatitis coronavirus 3 (MHV-3) decreased lung neutrophil infiltration, viral load, and tissue damage.

Conclusion and implications

These findings suggest that interplay of NEU1-MMP-9 induces neutrophil overactivation. In vivo, NEU may serve as a host-directed target to dampen neutrophil dysfunction during severe infections.

SUBMITTER: de Oliveira Formiga R 

PROVIDER: S-EPMC9877938 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.

de Oliveira Formiga Rodrigo R   Amaral Flávia C FC   Souza Camila F CF   Mendes Daniel A G B DAGB   Wanderley Carlos W S CWS   Lorenzini Cristina B CB   Santos Adara A AA   Antônia Juliana J   Faria Lucas F LF   Natale Caio C CC   Paula Nicholas M NM   Silva Priscila C S PCS   Fonseca Fernanda R FR   Aires Luan L   Heck Nicoli N   Starick Márick R MR   Queiroz-Junior Celso M CM   Santos Felipe R S FRS   de Souza Filipe R O FRO   Costa Vivian V VV   Barroso Shana P C SPC   Morrot Alexandre A   Van Weyenbergh Johan J   Sordi Regina R   Alisson-Silva Frederico F   Cunha Fernando Q FQ   Rocha Edroaldo L EL   Chollet-Martin Sylvie S   Hurtado-Nedelec Maria Margarita MM   Martin Clémence C   Burgel Pierre-Régis PR   Mansur Daniel S DS   Maurici Rosemeri R   Macauley Matthew S MS   Báfica André A   Witko-Sarsat Véronique V   Spiller Fernando F  

British journal of pharmacology 20230113 11


<h4>Background and purpose</h4>Neutrophil overstimulation plays a crucial role in tissue damage during severe infections. Because pathogen-derived neuraminidase (NEU) stimulates neutrophils, we investigated whether host NEU can be targeted to regulate the neutrophil dysregulation observed in severe infections.<h4>Experimental approach</h4>The effects of NEU inhibitors on lipopolysaccharide (LPS)-stimulated neutrophils from healthy donors or COVID-19 patients were determined by evaluating the she  ...[more]

Similar Datasets

| S-EPMC7668734 | biostudies-literature
2023-09-19 | GSE212191 | GEO
2024-08-28 | GSE243219 | GEO
| S-EPMC8464038 | biostudies-literature
| S-EPMC9226304 | biostudies-literature
2022-11-29 | GSE199816 | GEO
2024-08-28 | GSE243217 | GEO
2024-08-28 | GSE243218 | GEO
2023-03-24 | GSE222393 | GEO
| ST002477 | MetabolomicsWorkbench